Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26997 | 198 | 30.1 | 27% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1294 | 8163 | FOOD AND DRUG LAW JOURNAL//GENERIC SUBSTITUTION//DIRECT TO CONSUMER ADVERTISING |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | INTELLECTUAL PROPERTY PROGRAM | Address | 2 | 67% | 1% | 2 |
| 2 | CARDIORENAL DRUGS | Address | 1 | 50% | 1% | 1 |
| 3 | FOOD DRUG GRP | Address | 1 | 50% | 1% | 1 |
| 4 | LIFE SCI PRACTICE GRP | Address | 1 | 50% | 1% | 1 |
| 5 | RUSSIAN PROD COMPLEX | Address | 1 | 50% | 1% | 1 |
| 6 | SURG TECHNOL SURG EPIDEMIOL UNIT | Address | 1 | 50% | 1% | 1 |
| 7 | THERAPEUTIC PATENTS | Author keyword | 1 | 50% | 1% | 1 |
| 8 | US PATENT LAW | Author keyword | 1 | 50% | 1% | 1 |
| 9 | US PATENT TRADEMARK OFF | Address | 1 | 50% | 1% | 1 |
| 10 | HATCH WAXMAN | Author keyword | 1 | 22% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | THERAPEUTIC PATENTS | 1 | 50% | 1% | 1 | Search THERAPEUTIC+PATENTS | Search THERAPEUTIC+PATENTS |
| 2 | US PATENT LAW | 1 | 50% | 1% | 1 | Search US+PATENT+LAW | Search US+PATENT+LAW |
| 3 | HATCH WAXMAN | 1 | 22% | 1% | 2 | Search HATCH+WAXMAN | Search HATCH+WAXMAN |
| 4 | T H MORGAN | 0 | 33% | 1% | 1 | Search T+H+MORGAN | Search T+H+MORGAN |
| 5 | PATENT INFRINGEMENT LITIGATION | 0 | 25% | 1% | 1 | Search PATENT+INFRINGEMENT+LITIGATION | Search PATENT+INFRINGEMENT+LITIGATION |
| 6 | VALUE EXTRACTION | 0 | 25% | 1% | 1 | Search VALUE+EXTRACTION | Search VALUE+EXTRACTION |
| 7 | DISTOMER | 0 | 17% | 1% | 1 | Search DISTOMER | Search DISTOMER |
| 8 | WRITTEN DESCRIPTION | 0 | 17% | 1% | 1 | Search WRITTEN+DESCRIPTION | Search WRITTEN+DESCRIPTION |
| 9 | PATENT REFORM | 0 | 14% | 1% | 1 | Search PATENT+REFORM | Search PATENT+REFORM |
| 10 | EUTOMER | 0 | 13% | 1% | 1 | Search EUTOMER | Search EUTOMER |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTELLECTUAL PROPERTY DISPUTES | 9 | 83% | 3% | 5 |
| 2 | PATENT SETTLEMENTS | 6 | 80% | 2% | 4 |
| 3 | ANTICOMPETITIVE SETTLEMENT | 6 | 71% | 3% | 5 |
| 4 | 180 DAY EXCLUSIVITY | 1 | 100% | 1% | 2 |
| 5 | HATCH WAXMAN AMENDMENTS | 1 | 100% | 1% | 2 |
| 6 | HOVENKAMP | 1 | 100% | 1% | 2 |
| 7 | JANIS | 1 | 100% | 1% | 2 |
| 8 | LEMLEY | 1 | 100% | 1% | 2 |
| 9 | PRESUMPTIVE ILLEGALITY | 1 | 100% | 1% | 2 |
| 10 | DISPLAYS PRECLINICAL ACTIVITY | 1 | 50% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| The strategy of enantiomer patents of drugs | 2010 | 13 | 6 | 33% |
| Paying for delay: Pharmaceutical patent settlement as a regulatory design problem | 2006 | 29 | 40 | 23% |
| Urological flood or drought in 2006? | 2005 | 1 | 1 | 100% |
| Patenting genes and genetic research tools: Good or bad for innovation? | 2002 | 3 | 4 | 50% |
| Have the wheels come off the Asian-Pacific revolution? | 2006 | 0 | 2 | 100% |
| FDA policy and regulation of stereoisomers: Paradigm shift and the future of safer, more effective drugs | 1999 | 21 | 19 | 32% |
| An Asia-Pacific revolution? | 2005 | 1 | 2 | 50% |
| A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States | 2008 | 9 | 15 | 13% |
| Translation to success of surgical innovation | 2010 | 5 | 8 | 13% |
| CERTAINTY AND DISCRETION IN PATENT-LAW - THE ON SALE BAR, THE DOCTRINE OF EQUIVALENTS, AND JUDICIAL POWER IN THE FEDERAL CIRCUIT | 1994 | 8 | 26 | 19% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTELLECTUAL PROPERTY PROGRAM | 2 | 67% | 1.0% | 2 |
| 2 | CARDIORENAL DRUGS | 1 | 50% | 0.5% | 1 |
| 3 | FOOD DRUG GRP | 1 | 50% | 0.5% | 1 |
| 4 | LIFE SCI PRACTICE GRP | 1 | 50% | 0.5% | 1 |
| 5 | RUSSIAN PROD COMPLEX | 1 | 50% | 0.5% | 1 |
| 6 | SURG TECHNOL SURG EPIDEMIOL UNIT | 1 | 50% | 0.5% | 1 |
| 7 | US PATENT TRADEMARK OFF | 1 | 50% | 0.5% | 1 |
| 8 | OFF TECHNOL LICENSING | 0 | 33% | 0.5% | 1 |
| 9 | SEARLE LAW REGULAT ECON GROWTH | 0 | 33% | 0.5% | 1 |
| 10 | OFF CHIEF COUNSEL | 0 | 20% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000187765 | GENERIC SUBSTITUTION//GENERIC DRUGS//REFERENCE PRICING |
| 2 | 0.0000175787 | JOURNAL OF THE COPYRIGHT SOCIETY OF THE USA//IIC-INTERNATIONAL REVIEW OF INTELLECTUAL PROPERTY AND COMPETITION LAW//IIC-INTERNATIONAL REVIEW OF INDUSTRIAL PROPERTY AND COPYRIGHT LAW |
| 3 | 0.0000164887 | FOOD AND DRUG LAW JOURNAL//HUMANITARIAN DEVICE EXEMPTION//PREMARKET APPROVAL |
| 4 | 0.0000105954 | GENE PATENTS//INTELLECTUAL PROPERTY RIGHTS//EUROPEAN PATENT CONVENTION |
| 5 | 0.0000081187 | MULTIPLE INDUSTRIES//RETURN ON INNOVATION//VALUE TRANSFERENCE |
| 6 | 0.0000079958 | FOOD AND DRUG LAW JOURNAL//ADVOCACY NETWORK//AGR LAW |
| 7 | 0.0000078308 | PATENT ANALYSIS//PATENTS//PATENT CITATIONS |
| 8 | 0.0000077397 | ANTITRUST LAW JOURNAL//JOURNAL OF COMPETITION LAW & ECONOMICS//BUR COMPETIT |
| 9 | 0.0000073570 | BIOSIMILARS//BIOSIMILAR//ANTI ERYTHROPOIETIN ANTIBODIES |
| 10 | 0.0000059212 | COMPULSORY LICENSING//ACCESS TO MEDICINES//DOHA DECLARATION |